11C-MK-3168

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 11C-MK-3168, covering 2015-09-28 to 2015-09-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279 [Phase 1]

See pricing